Healthcare

In the 18 August 2026 announcement, AVITA said its multicentre, randomised PermeaDerm-I study met its primary endpoint on cost per percentage of total body surface area treated. The reported mean product cost was USD 148.70 per 1% of body surface area with PermeaDerm versus …

The company's March 2026 quarterly activities report described more than 50 active accounts proceeding through a structured sales process in the United States. The accounts were not all announced as contracted customers: the company distinguished early discussions from later stages such as proposals and …

The group reported that its software-as-a-service products were being delivered at 540 sites worldwide at 30 June 2026, a 39% increase compared with the preceding financial year-end. This is a measure of installation or service reach, rather than a direct count of paying patients. …

Database lock means the study dataset has reached a stage where the information is fixed for the planned analysis. It does not disclose the efficacy outcome. The company’s 21 October announcement narrowed the anticipated timing of the readout, following completion of the final participant …

Pathology services involve sample collection, processing and clinical testing. Laboratory capacity, collection networks and processing costs are important parts of the company’s operations. The group’s specialist Agilex Biolabs activities have a different service profile from mainstream pathology, so segment performance needs to be distinguished …

Medical imaging involves delivering examinations and interpreting results for referring medical practitioners. Integral Diagnostics Limited (ASX:IDX) works within this service model, where clinical quality, appropriate technology and access to specialist staff are essential. The business must coordinate equipment, practice locations and reporting workflows to …

Ryoncil is central to Mesoblast Limited (ASX:MSB)'s commercial operations. In July 2026, the company reported net Ryoncil revenue of US$36 million for the fourth fiscal quarter and US$115 million for the full fiscal year. These amounts refer to different reporting periods and should not …